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0051: TO EVALUATE THE EFFECT OF HYPERBARIC OXYGEN THERAPY ON
THE HEARING OUTCOME IN PATIENTS WITH SUDDEN SENSORINEURAL
HEARING LOSS
S. Agrawal*, N. Sharma, N. Banerjee. PGIMER & Dr. Ram Manohar Lohia
Hospital, India
Aim: To ascertain whether the addition of HBOT to conventional medical
treatment improves hearing outcome in patients with Sudden SNHL, to
assess the impact of patient-related and audio vestibular parameters on
prognosis, to document any adverse effects of HBOT.
Methods: 40 patients with Sudden SNHL, 18e60 years, were enrolled. 20
patients (Group A) received steroids, plasma expander, gingko biloba,
nicotinic acid, betahistine, and antiviral. 20 patients (Group B) received the
above with HBOT (10 sessions). Audiological assessments were performed
with pure tone audiometry on day 5,10,at each month's end, for 3 months.
Following parameters were noted: demographics (age, gender); tinnitus;
vertigo; time between onset of loss and initiation of treatment; severity of
hearing loss. Hearing outcomes were evaluated by four indices: cure rate,
marked recovery rate, recovery rate, and hearing gain.
Results:Mean hearing gainwas 31.5 + 20.0 dB inGroupB,whichwas higher
than in Group A,16.8 + 17.5 dB(p¼ 0.018). Marked recovery ratewas higher
in Group B(50%vs20%; p¼ 0.047).Patients treated within ﬁrst seven days of
onset showed higher hearing gains and marked recovery rates. Cure rate
was higher in patients without vertigo (19%vs0%; p ¼ 0.045).20%patients
suffered from adverse effects of HBOT, most common being otitis media.
Conclusion: Addition of HBOT to conventional treatment signiﬁcantly
improves the outcome of sudden deafness; its use should be encouraged as
an adjunctive therapy. Age, gender, tinnitus, severity of hearing loss did not
affect the outcome of sudden hearing loss. Presence of vertigo and initia-
tion of treatment more than seven days after onset were poor prognostic
factors. HBOT was a relatively benign intervention.0152: ANALYSIS OF PRO [-2] PSA: A NOVEL BIOMARKER THAT
SIGNIFICANTLY IMPROVES THE DETECTION OF PROSTATE CANCER
R. Foley 1,*, L. Gorman 1, D. Lundon 2, N. Shariﬁ 3, K. Murphy 1, A.
Tuzova 4, A. Perry 4, T.B. Murphy 1, R.W. Watson 1. 1University College* Corresponding author.
http://dx.doi.org/10.1016/j.ijsu.2015.07.017Dublin, Ireland; 2Mater Misericordiae University Hospital, Ireland;
3Beaumont Hospital, Ireland; 4 Trinity College, Ireland
Aim: In order to effectively select patients for prostate biopsy more
accurate biomarkers of disease are needed. The objective of this study
was to analyse the clinical utility of a novel biomarker; pro [-2] PSA in
order to inform the decision for prostate biopsy in an Irish cohort of
men.
Methods: The serum of 250 men from three tertiary referral centres with
pre-biopsy blood draws was analysed for tPSA, fPSA and pro [-2] PSA. From
this the phi score was calculated (pro [-2] PSA/fPSA)*√tPSA). Calibration
plots, ROC analysis as well as decision curve analysis were utilised to
ascertain the potential utility of the phi score.
Results: The phi score was well calibrated in this cohort demonstrating
good correlation between predicted probabilities and actual outcome. The
AUC for the phi score was 0.72 for the prediction of prostate cancer and
0.78 for the prediction of high grade prostate cancer (gleason  7),
compared to 0.62 and 0.70 for tPSA. Decision curve analysis demon-
strated net beneﬁt of the phi score over its entire range of risk
probabilities.
Conclusion: The measurement of pro [-2] PSA can increase the accuracy of
risk calculation in each individual patient thereby helping to better inform
the decision for prostate biopsy in a referral population.0334: OPTIMISATION OF BIOMATERIAL SURFACES FOR NEXT
GENERATION NEUROSURGICAL IMPLANTS
R. Bartlett*, B. Cousins. University College London, UK
Aim: Neurosurgically implanted electrical devices are used to treat a
range of severely debilitating disorders. However, their current use is
limited by poor long-term biocompatibility, and thus this research aimed
to investigate whether chemical modiﬁcation was useful strategy in
overcoming this.
Methods: Glass and gold substrates were chemically modiﬁed using
organosilane precursors to produce either methyl (eCH3), amine (eNH2)
or thiol (eSH) functionalised surfaces. Contact angle (q) measurements
were performed to validate the modiﬁcation process and PC-12 cells
cultured. Light microscopy and SEM provided information on cell behav-
iour, whilst cell-based assays were used to quantify metabolic activity and
proliferation.
Results: Thiol functionalised surfaces were found to confer signiﬁcantly
greater levels of cell adhesion (p ¼ 0.005), proliferation (p < 0.001),
Abstracts / International Journal of Surgery 23 (2015) S15eS134S16metabolic activity (p ¼ 0.002) and differentiation (p < 0.001) relative to
control glass substrates at day 7. Similar results were observed on gold, and
thiol surfaces were also found to initiate early neurodifferentiation in the
absence of trophic factors.
Conclusion: Organofunctionalisation potentially offers a simple and cost-
effective cross-platform technology through which the biocompatibility of
neurosurgical implants could be easily improved. Our results are highly
encouraging, yet it is now essential that work is repeated using a co-cul-
ture model to investigate the inﬂammatory component of device rejection.
0356: ORGAN DONATION REGISTRATION: EVIDENCE BASED
MARKETING?
R. Thomas 1,*, W. Scott 2, J. Forsythe 1, L. Marson 1. 1University of Edinburgh,
UK; 2 Scottish Government, UK
Aim: 778 Scots are waiting for a transplant and last year 43 died whilst
waiting. Only 42% of eligible Scots are on the organ donor register (ODR).
Apathy is a barrier: 32% of those unregistered said they would join,
demonstrating a potential focus for a targeted marketing campaign.
Methods: In 2005, the Scottish “Kill Jill” campaign focused on the
contemporary trend of voting for outcome (cost: £325,000). In 2008,
the “Connected”marketing had amore personal approach (cost: £615,000).
Results: “Kill Jill” increased new Scottish registrations by 33%, compared to
the 6.5% English increase over the same period. The 108,423 new regis-
trations should mean six additional renal transplants over a decade. The
subsequent “Connected” campaign generated 34,729 more registrations, a
1.8% growth in ODR. It was predicted that this would result in 2.6 extra
transplants.
Conclusion: Marketing is expensive and results are difﬁcult to quantify.
One renal transplant saves £214 000 per person compared to dialysis. If
only one of 108,423 donates both kidneys after death, the “Kill Jill”
campaign has paid for itself. The “Connected” campaign predicted that
each £1 spent, saves the NHS £5.28. ODR campaigns deliver a healthy re-
turn-of-interest and the initial considerable outlay should result in many
lives transformed and saved.0685: EXPLORING THE TUMOUR STROMA MACROPHAGES TO IDENTIFY
RESPONDERS TO RADIOTHERAPY IN LOCALLY ADVANCED RECTAL
CANCER
S. Shaikh*, A. Noshirwani, N. West, S. Perry, T. Maisey, D. Jayne. University
of Leeds, UK
Aim: Only half the patients with locally-invasive-rectal-carcinoma (LIRC)
respond to short-course-preoperative-neoadjuvant radiotherapy(SCPRT).
A predictive test enabling better patient selection could avoid undue ra-
diation exposure to poor-responders. Macrophages within the tumour
immune microenvironment with tumouricidal M1 and tumour-protective
M2 phenotypes could be modulating this response. This study investigates
the possible predictive value of M1 and M2 in identifying patients’ likely
response to SCPRT.
Methods: Dual-staining immunohistochemistry was performed on 29
biopsy and post-SCPRT resection LIRC specimens with CD68 as macro-
phagemarker, Human-Leukocyte-Antigen-DR(HLA-DR) as M1-marker and
Cluster-of-Differentiation-163(CD163) as M2-marker. Specimens were
scored for hot-and-random spots by Nuance-3.0.2 and compared with
patients’ outcome data.
Results: A signiﬁcant difference was found for high and low M1 percent-
ages with a tumour response of 20% and 80%, respectively (p ¼ 0.017). No
such difference was found for M2. The ratio of M1/M2 in biopsy vs.
resection samples was found to be signiﬁcantly different (p < 0.05), and
change in ratio producing a signiﬁcant mean (p ¼ 0.024).
Conclusion: Patients with a variable macrophage phenotype composi-
tion within LIRC biopsies respond differently to SCPRT. Further inves-
tigation involving a panel of macrophage/other immune-cell
markers could verify and validate these ﬁndings and develop them as
predictive tests identifying good-responders to radiotherapy in patients
with LIRC.0739: HEAD AND NECK CANCER DETECTION: THE EFFICACY OF THE 2-
WEEK-WAIT REFERRAL PATHWAY
T. Tikka 1,*, P. Pracy 1, V. Paleri 2. 1Queen Elizabeth Hospital, UK; 2 Freeman
Hospital, UK
Aim: Identify signiﬁcant factors in correct cancer diagnosis through the
ENT 2-week-wait referral pathway.
Methods: Retrospective review of 5083 patients' notes with possible head
and neck caner who were referred through the 2-week-referral pathway
from 2007 to 2010 in 2 tertiary UK Hospitals. Multivariate binary logistic
regression analysis was performed to identify signiﬁcant factors in cancer
diagnosis. The ﬁnal model was compared to amodel created by the current
NICE guidance.
Results: Low sensitivity and high speciﬁcity was found for all presenting
symptoms. Presence of hoarseness for more than 6 weeks; dysphagia for
more than 3 weeks; presence of blood in mouth with concurrent sensation
of lump in throat; the sensation of lump in neck ; sore throat; otalgia;
odynophagia; presence of otalgia with concurrent lump in throat sensa-
tion are highly statistically signiﬁcant symptoms for correct diagnosis of an
ENT cancer. Our ﬁnal suggested model has higher predictive value in
correct cancer diagnosis comparing to the NICE guidance model.
Conclusion: The current NICE referral guidance failed to increase detec-
tion rates of ENT cancers. We are recommending a new national referral
checklist, based on our logistic regression analysis, to be used by General
Practitioners when assessing patients with probable ENT cancer.
0777: A PROSPECTIVE STUDY OF CART, CHROMOGRANIN A,
CHROMOGRANIN B AND PANCREATIC POLYPEPTIDE IN THE
DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMOURS
S. Singagireson*, N. Martin, K. Murphy. Imperial College London, UK
Aim: Biochemical markers are an integral part of pancreatic neuroendo-
crine tumour (pNET) diagnosis, however, the current gold standard of
biomarkers, chromogranin-A (CgA) has signiﬁcant limitations. Recent
research has suggested other circulating markers including cocaine-and-
amphetamine-regulated-transcript (CART), chromogranin-B(CgB) and
pancreatic polypeptide(PP) may have utility as pNET diagnostic markers.
To investigate the sensitivities and speciﬁcities of measuring circulating
CART, CgA, CgB and PP for pNET diagnosis.
Methods: Plasma samples were obtained from patients with pNETs, non-
neuroendocrinepancreaticdisease (NNPD)andnon-pancreaticdisease (NPD)
and circulating concentrations of CART, CgA, CgB and PP were measured.
Results: Circulating CART was the only marker signiﬁcantly elevated by
pNETs compared to NPD (48.00 (35.75e67.00 pmol/L) [NPD] vs. 89.00
(66.00e147.0 pmol/L) [pNET], p < 0.01, n ¼ 7e42). CART was the most
sensitive marker for pNETs, with a sensitivity of 71%, compared to 29%,
25%, and 0% for CgA, CgB and PP respectively. It also had a speciﬁcity of 88%,
which was lower than the speciﬁcities of CgA, CgB and PP with 100%, 98%,
94% respectively.
Conclusion: These data suggest that circulating CART may be a more
sensitive and reliable marker than CgA, CgB or PP in pNET diagnosis which
may result in earlier diagnosis and so a greater proportion of resectable
tumours at presentation.
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0065: COGNITIVE TASK ANALYSIS PERFORMANCE OF SURGICAL
TRAINEES USING AN OPEN HERNIA REPAIR SIMULATOR
A.O. Rae*, M. Khatib, S. Sarker, F. Bello. Imperial College London, UK
Aim: To evaluate the use of an interactive open hernia simulator on the
cognitive task analysis performance of trainees compared to other
methods of acquiring the knowledge for the operation.
Methods: 32 foundation and core surgical trainees were randomised to
receive 1 of 4 interventions (interactive open hernia repair simulator) G1,
non-interactive open hernia repair simulator G2, a video tutorial of the
